INTRODUCTION
Vascular permeability factor (VPF)' is a potent mediator of vessel permeability first described in the conditioned media of several rodent and human tumor cell lines (Dvorak et al., 1979; Senger et al., 1983 Senger et al., , 1986 . VPF is readily detectable in tumor ascites fluids but not in normal serum or plasma. Taking advantage of its heparinbinding properties, VPF has been purified to homogeneity from the serum-free medium of cultured guinea pig tumor cells (Senger et al., 1987 and human U937 cells . Proteins from both sources have a molecular mass of 34-42 kDa and consist of two disulfide-linked subunits with identical N-ter-'Abbreviations used: bp, base pair; DMEM, Dulbecco's modified Eagle's medium; FSdGF, Folliculo-stellate-derived growth factor; GD-VEGF, glioma-derived VEGF; gVPF, guinea pig VPF; hVPF, human VPF; HBSS, Hank's balanced salt solution; PCR, polymerase chain reaction; PDGF, platelet-derived growth factor; SDS, sodium dodecyl sulfate; VEGF, vascular endothelial growth factor; VPF, vascular permeability factor. mini. More recently, a structurally similar protein, identified as a heparin-binding mitogen specific for endothelial cells, was purified from the culture medium of bovine pituitary-derived folliculo-stellate cells (vascular endothelial growth factor or VEGF, Ferrara and Henzel, 1989 ; folliculo-stellate-derived growth factor or FSdGF, Gospodarowicz et al., 1989) and from rat glioma cells (glioma-derived vascular endothelial growth factor or GD-VEGF, Conn et al., 1990b) . Protein sequencing and molecular cloning of human, bovine, and rat cDNAs (Keck et al., 1989; Leung et al., 1989; Tischer et al., 1989; Conn et al., 1990a) demonstrated that tumor VPF, pituitary VEGF/FSdGF, and glioma GD-VEGF are products of the same gene. The sequences also revealed limited but distinct homology of VPF/VEGF to plateletderived growth factor (PDGF). Alternative forms of the coding regions were isolated from both human and bovine cDNA libraries. Comparison of these cDNA sequences with recently isolated human genomic clones revealed that alternative splicing is involved in VPF/ VEGF mRNA biosynthesis (Tischer et al., 1991) . Col-©) 1992 by The American Society for Cell Biology lectively, the data indicate that at least three polypeptides are encoded by alternatively spliced VPF/VEGF transcript ( Figure 1) ; whether they have different biological activities or distinct subcellular localizations remains to be determined. The splicing pattern is conserved between VPF/VEGF and PDGF (Betsholtz et al., 1990; Tischer et al., 1991) .
VPF/VEGF has several biological activities and therefore may serve a variety of functions in vivo (for review, see Senger and Dvorak, 1992) . On a molar basis it is '50 000 times more potent than histamine at increasing microvascular permeability . In its capacity as both permeability and growth factor, VPF/VEGF very likely is responsible for fluid accumulation in solid and ascites tumors and for initiating and promoting tumor angiogenesis and stroma generation (Nagy et al., 1988) . In vitro and at subpicomolar concentrations, VPF/VEGF rapidly increases free cytosolic Ca21 in endothelial cells, apparently by activating a phosphoinositide-specific phospholipase C (Brock et al., 1991) . It has been shown also to stimulate von Willebrand factor release from endothelial cells (Brock et al., 1991) , to induce expression of endothelial cell tissue factor activity, and to promote monocyte migration (Clauss et al., 1990) . Thus, VPF/VEGF may have important roles in processes as diverse as neoplastic growth, wound healing, and inflammation.
To date, expression of VPF/VEGF has been demonstrated in rodent and human tumor cell lines, in bovine and mouse pituitary-derived cells (Ferrara and Henzel, 1989; Gospodarowicz et al., 1989; Plouet et al., 1989) , in rat corpus luteum (Phillips et al., 1990) , and recently, in cultured vascular smooth muscle cells (Tischer et al., 1991 (Dvorak et al., 1979) were cultured in DMEM containing 5% calf serum. Guinea pig resident macrophages were harvested from the peritoneal cavity and lungs by flushing with Hanks' balanced salt solution (HBSS). Alternatively, elicited macrophages were isolated from the peritoneal cavity 4-5 d after intraperitoneal injection of 20 ml sterile mineral oil (Hammond and Dvorak, 1972 (Keck et al., 1989; Leung et al., 1989) . The guinea pig PCR product exhibits very high sequence homology (>90%) with human, as well as bovine and rat, VPF/VEGF cDNAs (Leung et al., 1989; Tischer et al., 1989; Conn et al., 1990a (5-50 ,ug) were size-fractionated on 1.2% agarose containing 6% formaldehyde and transferred to Nytran membranes (Schleicher and Schuell, Keene, NH). Hybridization was carried out for 24 h at 42°C in 50% formamide, 5X SSPE, 2.5X Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), and 10% dextran sulphate (Sambrook et al., 1989) . DNA probes were labeled with [a-32P]dCTP (New England Nuclear, Boston, MA) to a specific activity of 1-2 X 109 cpm/,ug DNA using the random hexamer labeling method (Feinberg and Vogelstein, 1983) . Typically, 2-4 X 107 cpm Of [32p]_ labeled probe was used for a 70-cm2 filter in 10 ml of solution. Although human and guinea pig VPF sequences are >90% homologous and cross-hybridize, species-specific VPF probes were always used to maximize the signal. Final washes were in 0.1X SSC, 0.1% SDS at 65°C. The blots were exposed to Kodak (Rochester, NY) XAR-2 film with an intensifying screen at -70°C for 2-4 d. To control for total mRNA content and lack of degradation in the analyzed preparations, the blots were stripped and subsequently hybridized with a human f-actin probe (2 kb human f-actin cDNA, Clontech Laboratories, Palo Alto, CA).
In Situ Hybridization
Tissues were cut into 1 to 2-mm thick slices and fixed in 85% ethanol, 10% formalin, 5% acetic acid for 3 h, dehydrated in graded alcohols and xylene, and embedded in paraffin. Sections were cut at 5-7 ,um, mounted on 3-amino-propyltriethoxy-silane-(Sigma, St. Louis, MO) treated glass slides and rehydrated as described previously (ffrenchConstant et al., 1989) . For cytospins, 105 cells were washed with HBSS, centrifuged onto poly-D-lysine-treated slides, submerged in the same fixative for 10 min, and stored in 70% ethanol.
To prepare RNA probes, the pGEM construct with gVPF insert was linearized with HindIll and transcribed in vitro from the T7 polymerase promoter to yield the antisense probe; alternatively, the same construct was linearized with EcoRI and transcribed from the SP6 promoter to yield the sense (control) probe. Transcription reactions were carried out using a Riboprobe Gemini II kit (Promega) (Figure 1 ). The probes hybridized discretely to a -4.5-kb band in line 10 tumor cells and in several normal tissues (Figure 2 ). When the hybridization signal was particularly strong, a second faint band of -2.0 kb was also detectable on longer exposures and may represent a degradation product of the larger transcript.
Among the normal guinea pig tissues studied, lung gave the strongest signal (Figure 2A ). Other organs that also expressed substantial amounts of VPF mRNA included kidney, adrenal gland, and heart. Lower levels of VPF transcript were found in liver and spleen. We did not obtain convincing evidence for the presence of VPF transcripts in RNA isolated from whole normal guinea pig brain, pituitary, ovary, testis, skin, lymph nodes, stomach, or skeletal muscle. Among normal human tissues examined, lung and kidney contained levels of VPF mRNA similar to those found in the same tissues in guinea pigs. VPF transcript was also readily detected in human liver, gastric mucosa, and, at a lower level, in breast tissue.
Several lines of evidence indicate that the 4.5-kb RNA band identified in the several tissues mentioned above represents the VPF transcript and not that of another gene. First, hybridization reactions were carried out under very stringent conditions (see MATERIALS AND METHODS and Meinkoth and Wahl, 1984) . Second, the estimated molecular mass of the detected RNA is similar in guinea pig and human tissues and is very close to the reported size of the hVPF transcript (Leung et al., 1989; Tischer et al., 1991) . Finally, this RNA species is particularly abundant in line 10 tumor cells that previously have been shown to secrete large quantities of VPF (Senger et al., 1983) . It should be noted that the differences in size among the three splicing variants of this mRNA are too small to be detected by Northem blotting.
To identify cell types responsible for VPF transcription, we applied in situ hybridization with antisense and sense gVPF riboprobes to four guinea pig tissues that were strongly positive by Northem analysis. In normal lung, strong labeling with the antisense probe was observed over cells associated with the luminal surface of alveolar walls, i.e., in the distribution of pulmonary alveolar wall epithelial cells (Figure 3, A and  B) . In the kidney, label was confined to a population of cells at the periphery of glomerular loops, a location suggestive of glomerular epithelial cells (Figure 3 , C-E). In the heart, cardiac myocytes were labeled ( Figure  3F ). Finally, in sections of adrenal gland, label concentrated over epithelial cells of the outer cortex ( Figure  3G ). In all instances, grain density with the sense probe was at background levels (e.g., Figure 3H) We used in situ hybridization to compare VPF expression in resident lung and peritoneal macrophages with that in oil-elicited peritoneal macrophages. By use of the gVPF antisense probe, we observed strong specific labeling of elicited macrophages and line 10 tumor cells but not of resident alveolar or peritoneal macrophages ( Figure 5) . Moreover, Northern analysis performed on the RNA from lungs extracted before or after depletion of alveolar macrophages by bronchial lavage showed no difference in the amounts of VPF transcript ( Figure  4A, lanes 1 and 2) . Collectively, the data indicate that resident alveolar macrophages do not contribute significantly to VPF expression in normal lung. (Senger et al., 1986) . To address further the association of VPF expression with neoplastic transformation, we performed Northern analysis on RNA isolated from two matched pairs of nontumorigenic and tumorigenic human cell lines. The VPF mRNA level was substantially elevated in the tumorigenic cell lines (HT 1080 fibrosarcoma, MNNG HOS osteosarcoma) as compared with their nontumorigenic counterparts ( Figure 4B) .
VPF/VEGF Expression in Tumors and
In preliminary studies that compared human autochthonous carcinomas removed at surgery with corresponding normal tissues derived from the same patient, two of four colonic adenocarcinomas showed clearly increased levels of VPF mRNA compared with adjacent histologically normal bowel mucosa ( Figure 6A , cases 3 and 4). One of these two (case 4) also showed increased VPF expression in a metastasis to a lymph node found at the time of surgery. The single gastric adenocarcinoma we studied showed a relatively small increase in VPF mRNA above the level present in adjacent normal gastric mucosa. Of three renal tumors studied, VPF mRNA was increased markedly in one (a predominantly clear cell type, renal cell carcinoma), and it was reduced compared with normal kidney in another (a papillary variant of renal cell carcinoma); VPF transcript was not detectable in a Wilm's tumor of the kidney ( Figure 6B ).
DISCUSSION
An important finding of the present study is that the VPF gene is expressed in a wide variety of normal adult guinea pig and human tissues. As assessed by Northern analysis, the highest levels of VPF mRNA were found in normal lung, kidney, heart, and adrenal gland. Lower, but still readily detectable, VPF transcript levels were found in liver, spleen, and gastric mucosa, and to a lesser extent in breast. Several other tissues were negative, but Northern analysis may be insufficiently sensitive to detect transcripts produced by only a small Molecular Biology of the Cell fraction of cells in a heterologous mixture even if those few cells produce significant levels of transcript. Earlier in situ hybridization experiments (Phillips et al., 1990) described VPF transcription in the corpus luteum but not elsewhere in the ovary, suggesting hormonally regulated cell-specific control of VPF expression. Our failure to demonstrate VPF transcripts in RNA prepared from randomly collected guinea pig ovaries very likely reflects the absence of sufficient numbers of corpora lutea in those ovaries for detection by Northern analysis. We have, however, demonstrated the presence of VPF protein in guinea pig corpus luteum by immunohistochemistry (Sioussat, unpublished data), providing support for and supplementing the findings of Phillips et al. (1990) .
In situ hybridization was employed to define more specifically the source of VPF expression in several of the tissues found positive by Northern blotting. These experiments identified strongly hybridizing subpopulations of cells in the alveolar walls of the lung and in the renal glomeruli; in both instances, the microscopic location of these cells suggests that they are epithelial cells. Outer cortex epithelium of the adrenal gland and cardiac myocytes were also positive for VPF mRNA.
The finding of VPF mRNA in such a diversity of normal tissues provides important insights as to its role in normal physiology. The protein has several known biological activities, the two best characterized being the abilities to increase vascular permeability and to promote endothelial cell proliferation. Phillips et al. (1990) have suggested that the VPF synthesized in the ovary by cells of the corpus luteum might be responsible for inducing the substantial angiogenesis characteristic of this structure. However, angiogenesis is not a feature of normal adult lung, kidney, heart, or adrenal gland, and therefore the presence of readily detectable VPF transcripts in these organs requires another explanation. (Guyton, 1981; Granger and Perry, 1983) . This low level of vascular permeability is necessary for the transport into the tissues of essential nutrients, plasma proteins (including, for example, albumin-borne fatty acids and antibodies), and for clearance of waste products. The kidney is a special case in that the renal glomeruli provide an exceptionally permeable filtration system and many important diseases of the kidney result from impaired glomerular permeability (Cotran et al., 1989 We also detected VPF mRNA in oil-elicited peritoneal macrophages but not in resident peritoneal or alveolar macrophages. Oil induces an inflammatory response in the peritoneal cavity with resulting recruitment, proliferation, and activation of peritoneal macrophages. Thus, VPF expression seems to correlate with at least certain types of macrophage activation and may point to a role for macrophage-secreted VPF in the vascular hyperpermeability of chronic inflammation and cellular immunity . In this context, VPF joins a large group of known cytokines expressed by activated macrophages (Adams and Hamilton, 1984; Nathan, 1987) , including fibroblast growth factors, transforming growth factors, and PDGF. It has become increasingly clear that these cytokines have important functions as regulators in both inflammation and tissue repair after wounding.
Three classes of VPF clones that have been isolated from various cDNA libraries (Keck et al., 1989; Leung et al., 1989; Tischer et al., 1989; Conn et al., 1990a; Berse, unpublished data) contain three coding region variants. Tischer et al. (1991) have shown that the human VPF/VEGF gene consists of eight exons and that the three VPF/VEGF mRNAs arise by alternative splicing. Theoretically predicted physical properties of the three polypeptides encoded by these mRNA variants differ significantly, but there is no experimental evidence that they correspond to different biological activities. For this study, hybridization probes were designed specifically to detect all VPF mRNAs and did not discriminate among alternatively spliced transcripts. Additional experiments are required to determine whether different cells or tissues express different splicing variants of VPF.
Studies from our laboratory (Nagy et al., 1988; Dvorak et al., 1991) support the hypothesis that VPF plays an important role in aiding growth of some tumors by promoting both tumor angiogenesis and stroma generation. In accord with earlier findings (Senger et al., 1986) .k-A w expression was correlated with tumorigenicity in matched pairs of cultured cell lines. As yet preliminary studies of autochthonous tumors surgically removed from cancer patients gave mixed results. In some tumors, VPF expression was increased substantially relative to their normal tissue counterparts, whereas in others, VPF mRNA levels fell below those of corresponding control tissues or were not detected. The high expression of VPF by the clear cell variant of renal cell carcinoma correlates with its prominent vascularity, a typical feature of this tumor (Cotran et al., 1989) . In general, analysis of VPF mRNA levels in tumors by Northern blotting requires cautious interpretation. Solid tumors are comprised of both parenchyma (tumor cells) and stroma; if VPF is synthesized only by tumor cells, then Northern analyses performed on whole tumors that also include significant amounts of stroma will inevitably understate the amounts of VPF mRNA actually present in tumor cells. Alternatively, it is possible that only a small fraction of malignant cells in any given tumor synthesizes VPF; again in this case, even if such few cells made abundant VPF mRNA, it might be diluted out and difficult to detect by Northern analysis. In situ hybridization and immunohistochemistry will be helpful in determining with greater precision which tumor cells actually synthesize VPF. For all of these reasons, a much larger and more comprehensive survey of autochthonous tumors will be necessary before meaningful conclusions can be drawn as to the incidence of VPF expression in human malignancy.
